HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Clinical trials for HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost radiation for head and neck cancer
Disease control Recruiting nowThis early-phase trial is testing whether adding the experimental drug ipatasertib to standard chemotherapy and radiation can better control advanced head and neck cancer. About 46 adults with certain types of head and neck cancer will receive the combination to find the safest d…
Matched conditions: HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:33 UTC
-
New combo therapy aims to fight stubborn head and neck cancers
Disease control Recruiting nowThis early-phase trial is for people with head and neck cancer that didn't go away or came back after treatment. Researchers are testing whether giving immunotherapy (pembrolizumab) and radiation before and during surgery can kill more cancer cells. The main goal is to find out w…
Matched conditions: HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
Remote hearing tests could save cancer Patients' hearing
Knowledge-focused Recruiting nowThis study looks at whether offering hearing tests close to home or remotely can help more head and neck cancer patients get their hearing checked during and after treatment. Many patients on cisplatin chemotherapy or radiation may lose hearing, but traveling to the clinic for te…
Matched conditions: HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC